Intended for healthcare professionals

News

Half of trials supporting new cancer drug approval in Europe had high risk of bias

BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5619 (Published 19 September 2019) Cite this as: BMJ 2019;366:l5619

Linked Research

Design characteristics, risk of bias, and reporting of RCTs supporting approvals of cancer drugs by EMA

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: September 2019 to May 2022

Rendering graph...
AbstractFullPdf
Sep 2019147818248
Oct 20192595236
Nov 20191362513
Dec 2019135132
Jan 2020113219
Feb 20206153
Mar 20205172
Apr 20204861
May 20206360
Jun 20203921
Jul 20206022
Aug 202010130
Sep 20204750
Oct 20203430
Nov 20202741
Dec 20203974
Jan 20213731
Feb 20216122
Mar 20213221
Apr 20213711
May 20214025
Jun 20211300
Jul 20213922
Aug 20211300
Sep 20213151
Oct 20214152
Nov 2021800
Dec 2021800
Jan 20223200
Feb 2022720
Mar 2022600
Apr 2022831
May 2022900
Total3113370138